Delivery Order SPE2DB22D3011-SPE2DB24FP7QU

Award Date 11/15/23
Potential Completion Date 11/16/23
Potential Value $62K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical worth $1,391.76 to supply 4562597830 MENQUADFI VIAL 0.5ML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies to be delivered by October 26, 2023. No set-aside designation was applied to this order, which was issued against an existing indefinite-delivery contract between Amerisourcebergen and...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $13,090 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4562909067 MENQUADFI VIAL 0.5ML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by November 28, 2023. No set-aside designation was used for this order placed against an existing indefinite delivery contract held by Amerisourcebergen Drug...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for $8,002.62. The order is for the supply of 4562680298 MENQUADFI vials in quantities of 0.5 milliliters each. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion scheduled for November 3, 2023. No set-aside designation was applied to this order, which was issued against an existing...
Amerisourcebergen Drug Corp has received a $1,053.72 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4563098773 MENQUADFI VIAL 0.5ML. The delivery order was awarded on December 14, 2023 against an indefinite delivery contract with no set aside designation used. Performance will occur at Amerisourcebergen's Conshohocken, Pennsylvania facility with completion by December 15, 2023. As a leading pharmaceutical distributor, Amerisourcebergen...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,044.21 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 4562152862 doses of MENQUADFI vaccine vials. The single day contract has a period of performance from September 13, 2023 through September 14, 2023. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No subcontractors or set aside designations...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical worth $2,087.64 to supply 4562868773 MENQUADFI VIAL 0.5ML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 21, 2023. No set-aside designation was applied to this award made against an indefinite-delivery contract held by Amerisourcebergen with DLA Troop Support Medical to provide...
Amerisourcebergen Drug Corp has received a $1,391.76 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4562690583 MENQUADFI VIAL 0.5ML. The delivery order was awarded on November 2, 2023 against an indefinite delivery contract held by Amerisourcebergen, with performance to be completed by November 3, 2023. To be delivered to the agency's location in Conshohocken, Pennsylvania, the products will support DLA Troop Support Medical's provision of...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $1,391.76 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4562954011 MENQUADFI VIAL 0.5ML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 1, 2023. No set-aside designation was applied to this award made against an indefinite delivery contract held by Amerisourcebergen Drug Corp to...
Amerisourcebergen Drug Corp has received a $1,043.82 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4562937617 MENQUADFI VIAL 0.5ML. The order was awarded on November 29, 2023 under the company's existing contracts with no set-aside designation specified. Performance will occur at Amerisourcebergen's Conshohocken, Pennsylvania facility by the November 30, 2023 completion date. As a leading pharmaceutical distributor, Amerisourcebergen Drug...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,053.72 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 4561458869 doses of MENQUADFI vaccine in 0.5mL vials. Performance will take place in Conshohocken, Pennsylvania over one day in July 2023. The delivery order was issued under DLA Troop Support Medical's prime vendor pharmaceuticals contract to supply medical products and services to the...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FP7QU
    Delivery Order

Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at $62,401.56 by the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562821605 MENQUADFI VIAL 0.5ML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by November 16, 2023. This order was issued against an indefinite-delivery contract held by Amerisourcebergen Drug Corp to provide pharmaceuticals and medical supplies in support of DLA programs. No set-aside designation was applied to this award to supply meningococcal vaccines and related products for military medical facilities.

Generated 2/14/24, 10:42 AM